pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton chemical exchange saturation transfer echoplanar imaging (CEST EPI). by Ellingson, Benjamin M et al.
UCLA
UCLA Previously Published Works
Title
pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton 
chemical exchange saturation transfer echoplanar imaging (CEST EPI).
Permalink
https://escholarship.org/uc/item/46q7d75v
Authors
Ellingson, Benjamin M
Yao, Jingwen
Raymond, Catalina
et al.
Publication Date
2019
DOI
10.1016/j.nicl.2019.101736
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Contents lists available at ScienceDirect
NeuroImage: Clinical
journal homepage: www.elsevier.com/locate/ynicl
pH-weighted molecular MRI in human traumatic brain injury (TBI) using
amine proton chemical exchange saturation transfer echoplanar imaging
(CEST EPI)
Benjamin M. Ellingsona,d,⁎, Jingwen Yaoa,c, Catalina Raymonda,b, Ararat Chakhoyana,b,
Kasra Khatibie, Noriko Salamonb, J. Pablo Villablancab, Ina Wannere, Courtney R. Reale,
Azim Laiwallae, David L. McArthure, Martin M. Montid,e, David A. Hovdae, Paul M. Vespae
aUCLA Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
bDept. of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
c Dept. of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California Los Angeles, Los Angeles, CA, USA
dDept. of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
e Dept. of Neurosurgery, UCLA Brain Injury Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
A R T I C L E I N F O
Keywords:
CEST
pH imaging
Traumatic brain injury
TBI
A B S T R A C T
Cerebral acidosis is a consequence of secondary injury mechanisms following traumatic brain injury (TBI), in-
cluding excitotoxicity and ischemia, with potentially significant clinical implications. However, there remains an
unmet clinical need for technology for non-invasive, high resolution pH imaging of human TBI for studying
metabolic changes following injury. The current study examined 17 patients with TBI and 20 healthy controls
using amine chemical exchange saturation transfer echoplanar imaging (CEST EPI), a novel pH-weighted mo-
lecular MR imaging technique, on a clinical 3T MR scanner. Results showed significantly elevated pH-weighted
image contrast (MTRasym at 3 ppm) in areas of T2 hyperintensity or edema (P < 0.0001), and a strong negative
correlation with Glasgow Coma Scale (GCS) at the time of the MRI exam (R2= 0.4777, P= 0.0021), Glasgow
Outcome Scale - Extended (GOSE) at 6 months from injury (R2=0.5334, P= 0.0107), and a non-linear cor-
relation with the time from injury to MRI exam (R2=0.6317, P= 0.0004). This evidence suggests clinical
feasibility and potential value of pH-weighted amine CEST EPI as a high-resolution imaging tool for identifying
tissue most at risk for long-term damage due to cerebral acidosis.
1. Introduction
Traumatic brain injury (TBI) is a major world health problem (Ghajar,
2000; Maas et al., 2008) and it is one of the leading causes of mortality and
disability (Finfer and Cohen, 2001). A cascade of biological events occurs
following traumatic insult to the brain leading to long-term secondary brain
damage, including tissue ischemia from impaired cerebral perfusion (Coles
et al., 2002; Diringer et al., 2002), amino acid excitotoxicity (Faden et al.,
1989), and interstitial acidification (Hum and Traystman, 1996; Siesjo et al.,
1993) from the resulting energy depletion and metabolic crisis (Vespa et al.,
2005). Each of these physiologic changes have been shown to be directly or
indirectly related to the degree of neuronal damage following injury and
may be useful for predicting outcome. Reduced cerebral perfusion has been
shown to be linked with outcome (Kirkness et al., 2005; Prabhakar et al.,
2014), while the degree of excitotoxicity has also been linked with outcome
(Timofeev et al., 2011) and is the target of a variety of treatment strategies
(Willis et al., 2004). Extracellular acidosis within the brain following TBI
occurs due to metabolic dysfunction and results in a variety of subsequent
injury mechanisms including increased permeability of calcium acid-sensing
ion channels (Yermolaieva et al., 2004), further excitotoxic(McDonald et al.,
1998) or oxidative(Ying et al., 1999) injury, reduced glutamate uptake by
astrocytes(Swanson et al., 1995), impairment of astrocytes to maintain
glucose metabolism(Swanson and Benington, 1996), and blood-brain bar-
rier disruption(Nagy et al., 1985). Further, measures of extracellular pH,
which is intimately linked with intracellular pH(Mellergard et al., 1994),
has been shown to be a strong marker of metabolic dysfunction and has
been linked with increased mortality following TBI (Clausen et al., 2005;
Timofeev et al., 2013; Yokota et al., 2000). Despite human and
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experimental evidence suggesting acidification of the brain may occur after
TBI (McIntosh et al., 1987; Shiogai et al., 1999; Zauner et al., 2002), there
remains a critical need for tools to non-invasively identifying regions of the
brain at risk for low extracellular pH in patients following TBI.
Amine chemical exchange saturation transfer echoplanar imaging
(amine CEST EPI; Fig. 1A) is a fast, noninvasive molecular MRI technique
with sensitivity to amino acid concentration and pH (Harris et al., 2016;
Harris et al., 2018). By preparing the MRI signal through selective satura-
tion of the fast exchanging, pH-dependent amine protons (-NH2) on gluta-
mine or glutamate (Fig. 1B), amine CEST imaging results in signal contrast
in tissues with high glutamine or glutamate concentration and low pH. Since
there is a well-documented increase in both extracellular glutamate(Bullock
et al., 1998; Chamoun et al., 2010; Folkersma et al., 2011; Vespa et al.,
1998) and mobile glutamine(Harris et al., 2012; Palmer et al., 1993; Xu
et al., 2011) following TBI from damage to neurons and astrocytes (Fig. 1C),
respectively, we theorized amine CEST EPI may provide unique insight into
the biologic status of the brain independent of other MR image contrasts.
We hypothesized areas of T2 hyperintensity adjacent to contusion would
exhibit high amine CEST EPI contrast consistent with excitotoxicity and
acidification of the brain, which may be useful in subsequent studies to
predicting patient outcome by more thoroughly identifying tissue most at
risk for long-term damage.
2. Materials and methods
2.1. Theory
The magnetization of water protons undergoing two-compartment
chemical exchange with amine protons is described by the Bloch-
McConnell equations (Woessner et al., 2005) in the form of:
=M X M cd t
dt
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pool a and pool b represent the water and amine protons, respectively;
Maz0 and Mbz0 are the equilibrium magnetizations of water and amine
protons, respectively; kb is the exchange rate of protons from pool b to
pool a; ka is the exchange rate of protons from pool a to pool b as given
by (Mb0/Ma0)·kb; ω1 is the RF pulse amplitude as given by ω1= γB1(t),
where γ is the gyromagnetic ratio and B1(t) is given in μT; δa=ω−ωa
and δb=ω−ωb, where ω is the applied radiofrequency (RF) irradia-
tion frequency, ωa is the water proton resonance frequency, and ωb is
the amine proton resonance frequency; T1a and T1b are the longitudinal
relaxation times of water and amine protons, respectively; and
C1a= (1/T1a)+ ka, C2a= (1/T2a)+ ka, C1b= (1/T1b)+ kb, C2b= (1/
T2b)+ kb represent the sum of exchange and relaxation rates. Eq. 1 can
be solved analytically to yield=M M X c X ct e( ) · ( / ) ( / )Xt 0 (3)
The effects of pH on the CEST signal can then be modeled by ac-
counting for the chemical exchange rate between amine and water
protons. The chemical exchange between amine and water protons can
be characterized as a base-catalyzed process, governed by the equation:= +k k k 10b base pH0 (14 ) (4)
where k0 is the default exchange rate, kbase is the base-catalyzed rate
constant, and kb is the exchange rate of protons from the metabolite
proton pool to the water pool (Liepinsh and Otting, 1996).
2.2. Phantom preparation and estimation of exchange rate constants
To determine the constants k0 and kbase for amino acid amines, a
series of glutamine and glutamate phantoms with pH ranging from 4.8
to 7.5 were prepared for MRI evaluation. Glutamine or glutamate were
combined with phosphate-buffered saline (PBS) in 50mL falcon tubes
to reach a concentration of 50mM. 0.5 mM Gd-DTPA (Magnevist®) was
then into each phantom solution to reduce relaxation times (i.e. T1 and
T2) near physiologic levels. The pH values of sample solutions were
then titrated to 18 different values ranging from 4.8 to 7.5, with acid
(1 N HCl) and base (1 N NaOH) solution. Phantom pH values were re-
recorded after the MRI scanning and used as the final pH values for data
fitting using the Bloch-McConnell equations described previously.
2.3. Mathematical simulations of CEST effects
To demonstrate the relationship between amine CEST image con-
trast and pH for both glutamine and glutamate we employed the Bloch-
McConnell simulation framework for CEST EPI previously described
(Harris et al., 2016), using exchange rate values estimated from
phantom experiments. Specifically, we simulated the z-spectrum from
pH values ranging from 5.5 through 8.0 by first assuming the con-
centration of amine protons was 50mM, which is reasonable
Fig. 1. A) MRI pulse sequence diagram for fast chemical Exchange saturation transfer echo planar imaging (CEST EPI) through one repetition. B) Diagram showing
sites of amine proton off-resonance excitation on glutamine (a), which undergoes pH-dependent chemical exchange with the bulk water pool (b). Similarly, glutamate
(c) also has exchangeable amine protons, leading to similar CEST effects. C) Diagram showing the glutamine (Gln)-glutamate (Glu) cycle. Glutamate is released from
the post-synaptic neuron by either damage to the neuron or normal electrochemical activity. In functioning astrocytes, Glu is transported into the cell where it is
converted to Gln via glutamine synthase (GS). Gln within the astrocytes is then shuttled to functioning neurons for Glutamate production by phasphate-activated
glutaminase (PAG) or released into the extracellular space in the presence of traumatic insult to either the astrocyte or neuron.
B.M. Ellingson, et al. NeuroImage: Clinical 22 (2019) 101736
2
considering 1) the concentration of amino acids in normal neural tis-
sues has been estimated around 20–25mM (Perry et al., 1971); 2) many
amino acid derivative metabolites including norepinephrine, 5-hydro-
xytryptophan, levodopa and other neurotransmitters possess a similar
amine functional group that will also contribute to the CEST signal at
3.0 ppm; and 3) we have previously shown these amino acids exhibit
similar pH-dependent exchange rate characteristics and CEST effects
(Harris et al., 2015). Additionally, we assumed the MR characteristics
of water protons were similar to values in normal white matter
(T1a= 1.22 s, T2a= 0.107 s) (Harris et al., 2015; Wright et al., 2008),
assumed the MR characteristics of the amine protons were similar to
those in the literature (T1b= 0.2 s and T2b= 0.1 s) (Choi et al., 2006; Li
et al., 2008; Traber et al., 2004; Woessner et al., 2005), and used a set of
3× 100ms Gaussian radiofrequency CEST saturation pulses with an
amplitude of 6 μT, similar to previous studies (Harris et al., 2016; Harris
et al., 2018). Lastly, using similar values of T1 and the exchange rates
estimated from the phantom experiments, we simulated the CEST signal
for a range of concentrations from 5mM to 50mM and a range of
transverse relaxation times from T2=50ms to 500ms.
2.4. Quantification of CEST contrast
During a CEST imaging experiment, the RF saturation frequency ω is
swept across a range of values to obtain a “z-spectrum” (Bryant, 1996).
To reduce the effects of T1 and T2 weighting along with other variables,
the attenuation of bulk water magnetization following a saturation
pulse is often described by the magnetization transfer ratio (MTR),
given by:
=MTR S
S
( ) ( )
0 (5)
where S(ω) is the magnitude of water proton MR signal available after
the saturation pulse with frequency ω and S0 is the MR signal available
without application of any RF saturation pulses. Since MTR can be af-
fected by symmetric effects of direct water saturation and conventional
magnetization transfer effects, CEST contrast is often described by the
asymmetry in the magnetization transfer ratio (MTRasym) with respect
to water proton resonance:
=MTR S S
S
( ) ( ) ( )asym
0 (6)
For the current simulation, MTR at spectral points between −5.0
and +5.0 ppm were calculated to obtain simulated z-spectra in these
tissues, and the MTRasym at 3.0 ppm was used as a final measure of pH-
dependent amine CEST contrast for use in subsequent patient studies.
2.5. Human participants
A total of 17 patients with traumatic brain injury and 20 healthy
volunteers were enrolled in this prospective, Health Insurance
Portability and Accountability Act (HIPAA) compliant study approved
by the Institutional Review Board at our institution. All patients and
volunteers signed informed written consent to have advanced imaging
collected. A summary of TBI patient demographics is shown in Table 1.
2.6. Magnetic resonance imaging
All patients underwent anatomic and amine CEST-EPI on a 3T MR
scanner (Siemens Trio, Prisma, or Skyra; Siemens Medical; Erlangen,
Germany). All patients received a standardized anatomic imaging
protocol consisting of at least T2-weighted turbo spin echo images,
diffusion tensor images (DTI), susceptibility-weighted gradient echo
images (SWI), fluid-attenuated inversion recovery (FLAIR) images, and
1mm isotropic parameter matched 3D inversion-recovery gradient re-
called echo (IR-GRE) images. Amine CEST-EPI was collected with the
following scan parameters: field-of-view (FOV)=256×256mm, Ta
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matrix size= 128×128, number of slices= 25, slice thick-
ness= 4mm with no interslice gap, TE/TR=27/380ms,
bandwidth= 1628Hz, and generalized autocalibrating partially par-
allel acquisition (GRAPPA) factor= 2. Off-resonance saturation was
applied using a pulse train of 3×100ms Gaussian pulses with ampli-
tude of 6 μT, with spoiling gradients to remove transverse magnetiza-
tion prior to each readout. A total of 25 off-resonance, or “z-spectral”
points were sampled at frequency offsets of: −3.4 to −2.6 ppm, −0.3
to +0.3 ppm, and +2.6 to +3.4 ppm, all in increments of 0.1 ppm.
Total scan time for CEST-EPI was approximately 6min.
2.7. ΔB0 map estimation using iterative down-sampling estimation with
Lorentzian fitting
In order to estimate the static magnetic field distortion, ΔB0, we
employed a novel method using iterative down-sampling with
Lorentzian fitting (Yao et al., 2018). Briefly, all CEST data were first
preprocessed with motion correction (mcflirt function, FSL; Oxford)
(Jenkinson et al., 2002). Next, a slice-by-slice ΔB0 map estimation was
achieved by first normalizing the raw CEST data with respect to the S0
reference scan data, resulting in z-spectral measurements, then per-
forming k-means clustering cluster the pixels with similar patterns in
the z-spectrum. The number of clusters for each iteration was set to 3m,
where m is the iteration number. Next, the average z-spectrum data was
estimated across all pixels within the same cluster, and then the mean z-
spectrum data were fit to the Lorentzian function in the form:
+c– cx a b( )2 , where a indicates the shift in z-spectral center point, b re-
lates to the width of the Lorentzian shape, c and b together determine
the y-scaling of the function. The constraint bound for ΔB0 estimation
was set to± 1/m ppm. The magnetic field distortion, or inhomogeneity
in the static magnetic field (ΔB0), was estimated by the value of a in the
Lorentzian model and subsequently stored for all pixels. Lastly, a 3D
Gaussian filter with standard deviation of unity was applied to the final
ΔB0 map to remove potential erroneous estimations.
2.8. Region of interest selection
All images were registered to high-resolution, 1mm isotropic T1-
weighted images using a 6° of freedom rigid body transformation and
mutual information cost function (FSL, FMRIB, Oxford, UK) for sub-
sequent analyses. MTRasym at 3 ppm and magnetic field fluctuations
(ΔB0) were measured within areas of T2 hyperintensity along with areas
of contusion as defined by signal voids on susceptibility (T2*) weighted
gradient echo images. Additionally, regions with apparent diffusion
coefficient (ADC)<0.6 um2/ms, suggestive of ischemia, were included.
Measurements in patients with multiple sites of T2 hyperintensity,
contusion, or potential ischemia were averaged together resulting in a
single measurement per patient. As a reference, a 2 cm diameter
spherical region of interest was identified within normal-appearing
white matter (NAWM), distal from any apparent lesion, hemorrhage or
contusion as well as a similar region of interest in white matter within
the brains of healthy volunteers. Line plots ranging from 13 to 20mm
were created by traversing the edge of the T2 hyperintense lesion in TBI
patients in order to document any apparent spatial colocalization of
acidic and ischemic tissue using MTRasym and ADC, respectively.
2.9. Clinical examination and outcome measures
The Glasgow Coma Scale (GCS) is a commonly used clinical mea-
sure of initial TBI severity, has been shown to be an early prognostic
marker for outcome (Jiang et al., 2002), and is inversely correlated with
likelihood of significant morbidity and mortality (Jiang et al., 2002;
Lawrence F. Marshall et al., 1991). Average GCS at the time of MRI was
7.4 ± 0.9 S.E.M. (range= 3 to 14). Additionally, we evaluated the
extended Glasgow outcome scale (GOSE) at 6months from the time of
injury as a widely accepted clinical measure of outcome in patients with
TBI (Jiang et al., 2002; Marshall et al., 1991; Levin et al., 2001;
Woischneck and Firsching, 1998). Six-month GOSE scores were avail-
able for 11 of the 17 patients in the current study and averaged
4.2 ± 0.6 S.E.M. (range=1 to 8). In the current study we tested the
hypothesis that CEST measures of MTRasym at 3 ppm within T2 hyper-
intense areas adjacent to contused tissue correlated with GCS at the
time of the MRI examination and could predict GOSE 6months fol-
lowing initial injury.
3. Statistical analyses
All values are presented as mean ± standard error of the mean
(S.E.M.). A linear mixed effects model and expected marginal means
estimations were used to compare measurements of MTRasym at 3 ppm
in regions of normal appearing white matter (NAWM), T2 hyperintense
regions, areas of contusion, areas of potential ischemia as indicated by
ADC<0.6 um2/ms, and healthy white matter from control partici-
pants. Similarly, a linear mixed effects model and expected marginal
means estimations were used to compare measurements of ΔB0 at
3 ppm in regions of normal appearing white matter (NAWM), T2 hy-
perintense regions, areas of contusion, and measurements from white
matter in healthy volunteers. A total of 5 comparisons were performed
for MTRasym and ΔB0 at 3 ppm, so a Bonferroni-corrected p-value of
Fig. 2. Amine CEST images of A) glutamine and B) glutamate phantoms with a
concentration of 50mM and varying pH. C) Physical MRI measurements and
Bloch-McConnell mathematical model fits for glutamine and glutamate at 5mM
and various pH values used to estimate pH-dependent exchange rates.
B.M. Ellingson, et al. NeuroImage: Clinical 22 (2019) 101736
4
0.01 was used to indicate statistical significance. Additionally, linear
regression was used to compare CEST measures of MTRasym at 3 ppm
within areas of T2 hyperintensity to both GCS at the time of MRI ex-
amination and GOSE at 6months from injury in patients with TBI. We
used nonlinear regression to test whether there was a logarithmic as-
sociation between the time between injury and MRI exam and MTRasym
at 3 ppm within areas T2 hyperintensity, which may suggest a higher
degree of excitotoxicity and acidosis in the early acute phases of TBI.
Lastly, we used a multiple linear regression using a combination of
CEST measures and the time between injury and MRI exam in order to
predict both GCS at the time of the MRI exam and GOSE at 6months
from injury.
4. Results
4.1. Phantom and simulation results
Phantom experiments involving CEST imaging of 50mM vials con-
taining glutamine and glutamate exhibited distinct changes at lower pH
values (Fig. 2A–B), consistent with previous studies. Results clearly showed
Fig. 3. A) Bloch-McConnell MR simulation results showing z-spectra for glutamine and glutamate at 50mM concentration for various pH. B) Zoomed region of the z-
spectrum showing increasing attenuation of the MR signal at offset frequencies around +3.0 ppm with decreasing pH. C) Asymmetry in the magnetization transfer
ratio about water resonance (MTRasym) for glutamine and glutamate at 50mM and various pH showing maximum asymmetry around +2–3.0 ppm. D) MTRasym at
3.0 ppm for glutamine and glutmate at various concentrations versus pH. E) MTRasym at 3.0 ppm for glutamine and glutamate at 50mM and various tissue T2
relaxation times versus pH.
B.M. Ellingson, et al. NeuroImage: Clinical 22 (2019) 101736
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a higher MTRasym at 3 ppm for pH values below around 7.0 in for glutamine
and around 7.5 for glutamate, with an estimated pH-dependent exchange
rate, in Hz, for glutamine and glutamate of
kex(Gln)=163.2+1.562×10[pH-3] and kex(Glu)=781+2.522×10[pH -
4], respectively (Fig. 2C).
Consistent with previous simulations and other studies (Harris et al.,
2016; Harris et al., 2015; Harris et al., 2018; Jin and Kim, 2014; Jin
et al., 2012; Sun et al., 2013), CEST measures of MTRasym at 3 ppm from
bulk water for both glutamine and glutamate demonstrated sensitivity
to pH, concentration, and T2 relaxation time. In particular, the z-
spectrum showed a slight decrease in normalized MR signal intensity
with decreasing pH assuming a constant glutamine concentration of
50mM (Fig. 3A–B). The MTRasym around 2-3 ppm showed the optimal
sensitivity to pH-related amine proton exchange (Fig. 3C), which in-
creased with increasing glutamine and glutamate concentration
(Fig. 3D) and increasing tissue T2 (Fig. 3E), which supports the hy-
pothesis that amine CEST EPI may provide value in identifying tissue at
risk of acidity due to excitotoxicity, particularly in areas of T2 hyper-
intensity.
4.2. MTRasym at 3 ppm within NAWM, T2 hyperintensity, contusion and
ischemia in TBI
Whole brain CEST-EPI data within healthy volunteers exhibited
relatively uniform, low values of MTRasym at 3 ppm (Fig. 4), averaging
0.58% ± 0.05% standard error of the mean (S.E.M.), which was si-
milar to average values of MTRasym at 3 ppm in a 2 cm diameter region
of relatively NAWM on anatomic MRI in TBI patients (Fig. 7A;
0.66% ± 0.05%). No difference in MTRasym at 3 ppm was observed
between NAWM in TBI patients and white matter in healthy volunteers
(P=0.2371). This was in stark contrast to MTRasym at 3 ppm within
lesions in TBI patients (Fig. 4). As illustrated in Fig. 5A–C and quanti-
fied in Fig. 7A, regions of T2 hyperintensity near areas of contusion
exhibited a significantly higher estimate of median MTRasym at 3 ppm
(1.62% ± 0.09%) compared with NAWM (Fig. 7A; P=0.0007).
Average values of MTRasym at 3 ppm in a 2 cm diameter region of re-
latively NAWM on anatomic MRI in TBI patients yielded an average
value of 0.66% ± 0.05% standard error of the mean (S.E.M.) (Fig. 7A).
In many cases, the acidic lesion appeared larger and more extensive
than lesions on anatomic MRI scans (Fig. 6A,B). In the 13 of 17 patients,
area of diffuse axonal injury, contusion or hemorrhage on anatomic
MRI (as indicated with T2*-weighted SWI) had negative MTRasym at
3 ppm and were easily identifiable on individual patient scans and were
often localized within area of the corpus callosum (Fig. 6A–C). Median
MTRasym at 3 ppm measured approximately −0.92% ± 0.25%, which
was significantly lower than NAWM and the T2 hyperintense lesion
(Fig. 7A; P < 0.0001). Areas of potential ischemia as indicated by
ADC<0.6 um2/ms exhibited an average MTRasym at 3 ppm around
0.86% ± 0.34%, which was not significantly different from NAWM
(Fig. 7A; P= 0.4988). No significant association was observed between
ADC and MTRasym at 3 ppm in areas of T2 hyperintensity (Fig. 7B;
R2=0.1267, P= 0.1609), as also illustrated by the line plots through
the T2 hyperintense lesions in Fig. 5A–C, nor between ADC and
MTRasym at 3 ppm in areas of contusion (Fig. 7C; R2= 0.1438,
P= 0.2013).
4.3. Magnetic field distortions (ΔB0) within NAWM, pericontusion, and
hemorrhage in TBI
Perturbations or distortions in the homogeneous, static magnetic
field within the MRI system can lead to errors in MTRasym measure-
ments and may provide unique sensitivity to regions of resolving blood
products. The median ΔB0 within NAWM averaged
0.042 ppm ± 0.011 ppm S.E.M., which was not significantly different
(ANOVA, P= 0.1287) from the ΔB0 estimated within areas of T2 hy-
perintensity (Fig. 7D; 0.039 ppm ± 0.018 ppm) or contusion (Fig. 7D;
0.077 ppm ± 0.012 ppm). No difference was observed between NAWM
in TBI patients and white matter from healthy volunteers (P=0.8213),
which averaged 0.045 ppm ± 0.009 ppm S.E.M..
4.4. Correlation between MTRasym at 3 ppm and clinical outcome
A strong negative correlation was observed between GCS at the time
of MRI and MTRasym at 3 ppm within contusion plus pericontusional
tissue (Fig. 8A; R2= 0.4777, P= 0.0021), suggesting patients with the
highest degree of brain acidity had worse function. Similarly, MTRasym
Fig. 4. Example of CEST-EPI estimates of MTRasym at 3 ppm across multiple slices in a A) a 23 year old healthy volunteer and B) a 22 year old patient with TBI
(Subject #7).
B.M. Ellingson, et al. NeuroImage: Clinical 22 (2019) 101736
6
at 3 ppm was inversely correlated with GOSE at 6months (Fig. 8B;
R2=0.5334, P=0.0107), also suggesting patients with the lowest pH
had worse long-term outcomes. We also observed a significant non-
linear (logarithmic) association between MTRasym at 3 ppm and the
time between the injury and MRI exam (Fig. 8C; Model: log10(time from
injury)=B× [MTRasym@3 ppm]+C; R2=0.6317, P=0.0004), im-
plying a higher acidity during acute injury compared with more sub-
acute or chronic stages of TBI. Lastly, multiple linear regression sug-
gested a combination of MTRasym at 3 ppm along with the time between
injury and MRI could better predict GCS at the time of the MRI exam
(Fig. 8D; Model: GCS=B1× log10(time from injury)+B2× [MTRasym@
3 ppm]+C; R2= 0.5796, P=0.0004) and GOSE at 6months (Fig. 8E;
Model: GOSE=B1× log10(time from injury)+B2× [MTRasym@
3 ppm]+C; R2= 0.6539, P= 0.0026).
5. Discussion
Following TBI, a series of secondary brain damage occurs including
reduced cerebral blood flow, hypoxia, and excitotoxicity (Bullock et al.,
1995; Bullock et al., 1998; Miller, 1985), all of which result in cerebral
acidosis (Clausen et al., 2005; Hovda et al., 1992; Kalimo et al., 1981).
Results from the current study are consistent with the hypothesis that
areas of T2 hyperintensity adjacent to contusions exhibit significant
acidosis, arising from excitotoxicity. Further, our results suggest the
degree of acidosis is highly correlated with both clinical function as
well as outcome, as evidenced by correlation with GCS at the time of
the MRI examination and GOSE at 6months, respectively. Eloquent
studies using multiparametric sensors inserted into the brain in patients
with TBI have verified a potential association between low extracellular
pH and outcomes including mortality (Gupta et al., 2004; Timofeev
Fig. 5. T2-weighted anatomic MRI (far left column), pH-weighted amine CEST EPI (MTRasym at 3 ppm, left column), apparent diffusion coefficient (ADC) map (right
column), and a line plot showing MTRasym at 3 ppm and ADC through the T2 hyperintense lesion (far right column) in A) a 22 year old male patient (Subject #7) with
a left temporal hemorrhagic contusion, subarachnoid hemorrhage, and subdural hematoma following being struck by a motor vehicle; B) a 24 year old male (Subject
#8) with a series of frontal extra-axial hematomas, significant midline shift from cerebral edema, and scattered contusions after being hit on a motorcycle by a motor
vehicle; and C) a 84 year old male patient (Subject #15) suffered a presumed fall resulting in right frontoparietal and left temporal contusions, subdural hematoma,
and subarachnoid hemorrhage. Red arrows on T2-weighted images show sites of T2 hyperintense lesions. Red lines on ADC maps show where line plot measurements
were obtained. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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et al., 2013). Interestingly, we also observed a correlation between time
from initial injury and degree of acidosis as evidenced by CEST con-
trast, which appears to be consistent with these same studies involving
temporal pH monitoring using intracranial sensors, which showed
acidic pH measurements reversing or normalizing in subsequent days
following injury (Timofeev et al., 2013).
Few studies have used molecular MR imaging to evaluate pH
changes following TBI, and the current study represents the first to
utilize amine CEST EPI on 3T clinical MR systems to evaluate acidosis in
human TBI at high spatial resolution. A number of preclinical studies
have shown alterations in intra- and extracellular pH using phos-
phorous nuclear magnetic resonance (31P NMR) spectroscopic techni-
ques (McIntosh et al., 1987; Vink et al., 1987). However, 31P NMR has
extremely low sensitivity, therefore data must be acquired using large
voxels and long scan times, making it less suitable for routine clinical
examination and differentiation of acidic subregions in heterogeneous
lesions. A recent study by Wang et al. (2017) utilized amide proton
transfer (APT) CEST imaging on a preclinical MR system (4.7T) in un-
treated rats following TBI, noting a characteristic decrease in MTRasym at
3.5 ppm (for amide protons), which has been shown to similarly reflect
a decreasing pH (Note: decreasing pH results in increased MTRasym at
3 ppm for amine protons and decreased MTRasym at 3.5 ppm for amide
protons (Jones et al., 2013)). Further, the approach in the current study
focusing on amine CEST imaging has specific advantages over APT
imaging including short radiofrequency irradiation times due to the fast
exchange rates of the amine protons, so fast readout strategies including
Fig. 6. T2-weighted anatomic MRI, pH-weighted amine CEST EPI, T2*-weighted MRI, and estimated magnetic field distortion (ΔB0) (Left-to-Right) for A) a 45 year
old male patient (Subject #1) with diffuse axonal injury and white matter microhemorrhages after suffering a fall from hang gliding; B) a 35 year old male patient
(Subject #2) who was struck by a motor vehicle and suffered bilateral subarachnoid and intraparenchymal hemorrhage; and C) a 28 year old male subject (Subject
#3) who suffered bilateral hemorrhagic contusions, subarachnoid hemorrhage in the frontal lobe, and subdural hematomas along the cerebral convexities after being
in a motor vehicle accident. Red arrows highlight areas of microbleeds and/or diffuse axonal injury within the corpus callosum. (For interpretation of the references
to color in this figure legend, the reader is referred to the web version of this article.)
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EPI can be used to obtain high resolution, whole brain images within
clinically realistic scan times.
It is important to point out a few limitations to the current study.
First, no correction for B1 inhomogeneities were performed. As B1 can
vary as much as± 20% (Sengupta et al., 2017), our simulations (not
shown) suggest that acidic tissue within areas of high amino acid
concentration (~50mM) can have MTRasym at 3 ppm that varies± 15%
(e.g. from 3.65% to 4.3%). Additionally, the results observed in the
current study should be taken as preliminary, since the relatively small
number of patients included may not represent the strength of trends
observed in a larger cohort of patients with different injury profiles.
Future studies with a larger number of patients and inclusion of B1
correction are warranted.
In summary, the current study demonstrates the feasibility and
potential clinical value of pH-weighted amine CEST EPI as a high-re-
solution imaging tool for identifying tissue most at risk for long-term
damage due to cerebral acidosis. Results suggest low pH in contusion
and pericontusional regions correlate strongly with clinical function
and 6-month outcome measures.
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